Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures

OBJECTIVE: Lusutrombopag is a thrombopoietin receptor agonist that improves thrombocytopenia in patients with chronic liver disease scheduled to undergo invasive procedures. However, information on the efficacy of repeated lusutrombopag treatment and factors associated with the treatment is scarce....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Intern Med
Päätekijät: Nishida, Yuno, Kawaoka, Tomokazu, Imamura, Michio, Namba, Maiko, Fujii, Yasutoshi, Uchikawa, Shinsuke, Ohya, Kazuki, Daijo, Kana, Teraoka, Yuji, Morio, Kei, Fujino, Hatsue, Nakahara, Takashi, Yamauchi, Masami, Hiramatsu, Akira, Tsuge, Masataka, Aikata, Hiroshi, Takahashi, Shoichi, Hayes, C. Nelson, Fukuhara, Takayuki, Tsuji, Keiji, Arataki, Keiko, Nagaoki, Yuko, Aisaka, Yasuyuki, Kamada, Koji, Kodama, Hideaki, Chayama, Kazuaki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Japanese Society of Internal Medicine 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8024946/
https://ncbi.nlm.nih.gov/pubmed/33087674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5930-20
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia